Rapamycin: An anti-cancer immunosuppressant?

This publication has 196 references indexed in Scilit:

• Bared essentials of CDK2 and cyclin E
  Nature Genetics, 2003
• Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
  Nature Cell Biology, 2003
• mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
  Cell, 2002
• l-Asparaginase Inhibits the Rapamycin-Targeted Signaling Pathway
  Biochemical and Biophysical Research Communications, 1999
• Mechanism of action of the immunosuppressant rapamycin
  Published by Elsevier ,1999
• High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
  Current Biology, 1998
• Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines
  Oncogene, 1998
• Expression, Enzyme Activity, and Subcellular Localization of Mammalian Target of Rapamycin in Insulin-Responsive Cells
  Biochemical and Biophysical Research Communications, 1997
• Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma
  Cancer, 1997
• Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
  Proceedings of the National Academy of Sciences, 1990